Brief: Impel Neuropharma Announces First Quarter 2021 Financial Results And Provides Business Update
07/06/2021 13:59
June 7 (Reuters) - Impel Neuropharma Inc IMPL.O :
* IMPEL NEUROPHARMA ANNOUNCES FIRST QUARTER 2021 FINANCIAL
RESULTS
AND PROVIDES BUSINESS UPDATE
* Q1 GAAP LOSS PER SHARE $15.09
* NON-GAAP NET LOSS PER SHARE WAS $0.54 FOR Q1 OF 2021
Source text for Eikon: ID:nGNX3vg1R6
Further company coverage: IMPL.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on IPI Legacy Liquidation Co
See all newsBrief: Impel Pharmaceuticals- On Dec 19, 2023, Co And Impel NeuroPharma Australia Commenced Voluntary Chapter 11 Proceedings
Brief: Impel Pharmaceuticals Says On Dec 1 Michael Kalb Gave Notice Of Resignation From Position As CFO With Last Day To Be December 31
U.S. STOCKS ON THE MOVE-iRobot Corp, Faraday Future, Fisker
U.S. STOCKS ON THE MOVE-iRobot Corp, Fisker Inc, International Seaways Inc
Brief: Impel Pharmaceuticals Receives Delisting Notice From Nasdaq